within Pharmacolibrary.Drugs.ATC.R;

model R06AE06
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.42,
    Cl             = 9.999999999999999e-06,
    adminDuration  = 600,
    adminMass      = 60 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.006,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0033333333333333335,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>R06AE06</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Oxatomide is a second-generation antihistamine primarily used for the symptomatic treatment of allergic conditions such as allergic rhinitis and urticaria. It acts as an H1 receptor antagonist and has additional antiallergic properties. Oxatomide is not currently widely marketed and its use is largely historical in some countries.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for healthy adult individuals based on limited published data and secondary summaries, as there are no detailed peer-reviewed PK studies with full model parameters available.</p><h4>References</h4><ol><li><p>Cavagni, G, et al., &amp; Benvenuti, C (1992). Pharmacokinetics of two oral liquid formulations of oxatomide in children. <i>International journal of clinical pharmacology, therapy, and toxicology</i> 30(8) 275–276. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/1356101/\">https://pubmed.ncbi.nlm.nih.gov/1356101</a></p></li><li><p>Kikuchi, K, et al., &amp; Sakai, K (2002). High-performance liquid chromatographic determination of oxatomide and its metabolite and its application to pharmacokinetic study in rat plasma. <i>Arzneimittel-Forschung</i> 52(10) 754–763. DOI:<a href=\"https://doi.org/10.1055/s-0031-1299962\">10.1055/s-0031-1299962</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/12442638/\">https://pubmed.ncbi.nlm.nih.gov/12442638</a></p></li><li><p>Paton, DM, &amp; Webster, DR (1985). Clinical pharmacokinetics of H1-receptor antagonists (the antihistamines). <i>Clinical pharmacokinetics</i> 10(6) 477–497. DOI:<a href=\"https://doi.org/10.2165/00003088-198510060-00002\">10.2165/00003088-198510060-00002</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/2866055/\">https://pubmed.ncbi.nlm.nih.gov/2866055</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end R06AE06;
